First in Human Study of ANXV (Recombinant Human Annexin A5) in Healthy Volunteers
Clinical trial NCT04850339 · COMPLETED
Trial details
- NCT number
- NCT04850339
- Sponsor
- Annexin Pharmaceuticals AB
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-21
- Primary completion
- 2021-10-27
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.